Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estudio de validación de Uromonitor en el diagnóstico Precoz de cáncer Vesical en Pacientes de Alto Riesgo Con Microhematuria

NCT05344937 is registered in ClinicalTrials.gov with Clinica Universidad de Navarra, Universidad de Navarra as lead sponsor.

NCT NCT05344937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05344937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estudio de validación de Uromonitor en el diagnóstico Precoz de cáncer Vesical en Pacientes de Alto Riesgo Con Microhematuria
Lead sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Phase
Observational
Overall status
Unknown status
Start date
May 2, 2022
Completion date
May 1, 2024
Enrollment
343 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer